Document:

Exhibit 10.1

 

OPTION TERMINATION AGREEMENT

 

THIS OPTION TERMINATION
AGREEMENT (this “Agreement”) is made as of January 30, 2020, by and between the undersigned (the “Option
Holder”) and Aevi Genomic Medicine, Inc., a Delaware corporation (the “Company”).

 

RECITALS 

 

A. The Company granted
to the Option Holder options to acquire shares of the Company’s common stock, par value $0.0001 per share, pursuant to that
certain Non-Qualified Stock Option Award Agreement between the Option Holder and the Company, dated September 13, 2013 (the “Option
Agreement,” with the options under such Option Agreement being the “Options”).

 

B. The Company recently
entered into an Agreement and Plan of Merger and Reorganization pursuant to which the Company will merge with and into a wholly
owned subsidiary of Cerecor Inc. (the “Merger”).

 

C. In connection with,
and contingent upon the closing of the Merger, the Option Holder desires to terminate the Option Agreement for no consideration.

 

NOW, THEREFORE,
in consideration of the premises and covenants contained herein, and other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Option Holder and the Company hereby agree as follows:

 

1. Termination
of Option Agreement. Effective immediately prior to the closing of the Merger, all of the Options will be cancelled and the
Option Agreement will be terminated and of no force and effect. The Option Holder hereby releases the Company and its affiliates
from any liability arising under or related to this Agreement, including with respect to the cancellation of the Options set forth
hereunder, and agrees not to bring any claims against the Company and its affiliates in respect of such cancelled Options.

 

2. Representations
and Warranties. By virtue of the execution and delivery of this Agreement by the Option Holder, the Option Holder hereby represents
and warrants to the Company that: (a) the Option Holder is the legal, record and beneficial owner of the Options and owns good,
valid, legal and marketable title to such Options, free and clear of all pledges, security interests, liens, claims, encumbrances,
agreements, rights of first refusal and options of any kind whatsoever, other than any spousal interest or such restrictions arising
under the Securities Act of 1933, as amended, or state securities laws; and (b) the Option Holder has had access to or the opportunity
to review sufficient written and oral information about the Company to allow the Option Holder to make an informed decision prior
to executing this Agreement. The Option Holder further acknowledges and agrees that neither the Company nor any other party has
made any oral or written representation, inducement, promise or agreement to the Option Holder in connection with the termination
of the Options, other than as expressly set forth in this Agreement.

 

3. Binding Effect;
Benefits. This Agreement shall be binding upon and inure to the benefit of the parties to this Agreement and their respective
successors and assigns. If the Option Holder is married, this Agreement is being contemporaneously herewith executed and delivered
by the Option Holder’s spouse. Nothing in this Agreement, express or implied, is intended or shall be construed to give any
person other than the Option Holder or the Company or their respective successors or assigns any legal or equitable right, remedy
or claim under or in respect of any agreement or any provision contained herein.

 

4. Entire Agreement.
This Agreement contains the entire agreement of the parties hereto relating to the subject matter hereof and supersedes all prior
agreements and understandings between the parties with respect to the subject matter hereof, and there are no written or oral terms
or representations made by either party other than those made herein.

 

5. Amendment; Termination.
No amendment or modification of this Agreement shall be valid or binding unless made in writing and duly executed by the party
against whom enforcement of any such amendment or modification is sought and making specific references to this Agreement.

 

     

     

    

 

6. Governing Law.
This Agreement and the rights and obligations of the parties hereunder shall be governed by the laws of the State of Delaware,
without regard to its conflicts of laws principles.

 

7. Counterparts.
This Agreement may be executed in any number of counterparts (including by facsimile or other electronic transmission), each of
which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

 

 

     

     

    

 

IN WITNESS WHEREOF, the Company
and the Option Holder have each executed this Agreement as of the date and year first above written.

 

 

	 	AEVI GENOMIC MEDICINE, INC.
	 	 	 
	 	 	 
	 	By:	/s/ Michael McInaw	 
	 	Name: Michael McInaw
	 	Title: Chief Financial Officer
	 	 	 
	 	 	 
	 	OPTION HOLDER:
	 	 	 
	 	 	 
	 	/s/ Michael F. Cola	 
	 	Name: Michael F. Cola 
	 	 	 
	 	 	 
	 	If applicable:
	 	OPTION HOLDER’S SPOUSE:
	 	 	 
	 	 	 
	 	/s/ MaryAnn Cola	 
	 	Name: MaryAnn Cola

 

 

 

 

 

[Signature
Page to Option Termination Agreement – M. Cola]Exhibit 10.2

 

OPTION TERMINATION AGREEMENT

 

THIS OPTION TERMINATION
AGREEMENT (this “Agreement”) is made as of January 30, 2020, by and between the undersigned (the “Option
Holder”) and Aevi Genomic Medicine, Inc., a Delaware corporation (the “Company”).

 

RECITALS 

 

A. The Company granted
to the Option Holder options to acquire shares of the Company’s common stock, par value $0.0001 per share, pursuant to that
certain Non-Qualified Stock Option Award Agreement between the Option Holder and the Company, dated September 13, 2013 (the “Option
Agreement,” with the options under such Option Agreement being the “Options”).

 

B. The Company recently
entered into an Agreement and Plan of Merger and Reorganization pursuant to which the Company will merge with and into a wholly
owned subsidiary of Cerecor Inc. (the “Merger”).

 

C. In connection with,
and contingent upon the closing of the Merger, the Option Holder desires to terminate the Option Agreement for no consideration.

 

NOW, THEREFORE,
in consideration of the premises and covenants contained herein, and other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Option Holder and the Company hereby agree as follows:

 

1. Termination
of Option Agreement. Effective immediately prior to the closing of the Merger, all of the Options will be cancelled and the
Option Agreement will be terminated and of no force and effect. The Option Holder hereby releases the Company and its affiliates
from any liability arising under or related to this Agreement, including with respect to the cancellation of the Options set forth
hereunder, and agrees not to bring any claims against the Company and its affiliates in respect of such cancelled Options.

 

2. Representations
and Warranties. By virtue of the execution and delivery of this Agreement by the Option Holder, the Option Holder hereby represents
and warrants to the Company that: (a) the Option Holder is the legal, record and beneficial owner of the Options and owns good,
valid, legal and marketable title to such Options, free and clear of all pledges, security interests, liens, claims, encumbrances,
agreements, rights of first refusal and options of any kind whatsoever, other than any spousal interest or such restrictions arising
under the Securities Act of 1933, as amended, or state securities laws; and (b) the Option Holder has had access to or the opportunity
to review sufficient written and oral information about the Company to allow the Option Holder to make an informed decision prior
to executing this Agreement. The Option Holder further acknowledges and agrees that neither the Company nor any other party has
made any oral or written representation, inducement, promise or agreement to the Option Holder in connection with the termination
of the Options, other than as expressly set forth in this Agreement.

 

3. Binding Effect;
Benefits. This Agreement shall be binding upon and inure to the benefit of the parties to this Agreement and their respective
successors and assigns. If the Option Holder is married, this Agreement is being contemporaneously herewith executed and delivered
by the Option Holder’s spouse. Nothing in this Agreement, express or implied, is intended or shall be construed to give any
person other than the Option Holder or the Company or their respective successors or assigns any legal or equitable right, remedy
or claim under or in respect of any agreement or any provision contained herein.

 

4. Entire Agreement.
This Agreement contains the entire agreement of the parties hereto relating to the subject matter hereof and supersedes all prior
agreements and understandings between the parties with respect to the subject matter hereof, and there are no written or oral terms
or representations made by either party other than those made herein.

 

5. Amendment; Termination.
No amendment or modification of this Agreement shall be valid or binding unless made in writing and duly executed by the party
against whom enforcement of any such amendment or modification is sought and making specific references to this Agreement.

 

     

     

    

 

6. Governing Law.
This Agreement and the rights and obligations of the parties hereunder shall be governed by the laws of the State of Delaware,
without regard to its conflicts of laws principles.

 

7. Counterparts.
This Agreement may be executed in any number of counterparts (including by facsimile or other electronic transmission), each of
which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

     

     

    

 

IN WITNESS WHEREOF, the Company
and the Option Holder have each executed this Agreement as of the date and year first above written.

 

 

	 	AEVI GENOMIC MEDICINE, INC.
	 	 	 
	 	 	 
	 	By:	/s/ Michael McInaw	 
	 	Name: Michael McInaw
	 	Title: Chief Financial Officer 
	 	 	 
	 	 	 
	 	OPTION HOLDER:
	 	 	 
	 	 	 
	 	/s/ Garry A. Neil	 
	 	Name: Garry A. Neil
	 	 	 
	 	 	 
	 	If applicable:
	 	OPTION HOLDER’S SPOUSE:
	 	 	 
	 	 	 
	 	/s/ Brigitte Neil	 
	 	Name: Brigitte Neil

 

 

 

 

 

[Signature
Page to Option Termination Agreement – G. Neil]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]